Venkataraman Balasubramanian

Array ( [id] => 1278661 [patent_doc_number] => 06645955 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-11-11 [patent_title] => '3,6-dihydroxy-24-amidyl steroid derivatives' [patent_app_type] => B1 [patent_app_number] => 09/560236 [patent_app_country] => US [patent_app_date] => 2000-04-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9604 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 186 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/645/06645955.pdf [firstpage_image] =>[orig_patent_app_number] => 09560236 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4383233 [patent_doc_number] => 06262043 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-07-17 [patent_title] => 'Estra-1,3,5(10),16-tetraene derivatives' [patent_app_type] => 1 [patent_app_number] => 9/548930 [patent_app_country] => US [patent_app_date] => 2000-04-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8232 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 34 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/262/06262043.pdf [firstpage_image] =>[orig_patent_app_number] => 548930 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1002551 [patent_doc_number] => 06909007 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2005-06-21 [patent_title] => 'Steroidal pharmaceutical compounds' [patent_app_type] => utility [patent_app_number] => 09/926327 [patent_app_country] => US [patent_app_date] => 2000-04-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10971 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/909/06909007.pdf [firstpage_image] =>[orig_patent_app_number] => 09926327 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4383202 [patent_doc_number] => 06277838 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-08-21 [patent_title] => 'Methods for allosteric modulation of the GABA receptor by members of the androstane and pregnane series' [patent_app_type] => 1 [patent_app_number] => 9/547041 [patent_app_country] => US [patent_app_date] => 2000-04-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 13 [patent_no_of_words] => 33967 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/277/06277838.pdf [firstpage_image] =>[orig_patent_app_number] => 547041 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 788188 [patent_doc_number] => 06987120 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2006-01-17 [patent_title] => 'Pharmaceutical compounds' [patent_app_type] => utility [patent_app_number] => 09/926322 [patent_app_country] => US [patent_app_date] => 2000-04-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18294 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/987/06987120.pdf [firstpage_image] =>[orig_patent_app_number] => 09926322 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4326449 [patent_doc_number] => 06329357 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-12-11 [patent_title] => 'Therapeutically effective 1.alpha., 25-dihydroxyvitamin D3 analogs and methods for treatment of vitamin D diseases' [patent_app_type] => 1 [patent_app_number] => 9/546314 [patent_app_country] => US [patent_app_date] => 2000-04-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 24 [patent_no_of_words] => 24852 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 183 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/329/06329357.pdf [firstpage_image] =>[orig_patent_app_number] => 546314 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4331849 [patent_doc_number] => 06313180 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-11-06 [patent_title] => 'Steroid compounds having contraceptive and anti-osteoporosis activity' [patent_app_type] => 1 [patent_app_number] => 9/538783 [patent_app_country] => US [patent_app_date] => 2000-03-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 9287 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/313/06313180.pdf [firstpage_image] =>[orig_patent_app_number] => 538783 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1256336 [patent_doc_number] => 06667299 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-12-23 [patent_title] => 'Pharmaceutical compositions and treatment methods' [patent_app_type] => B1 [patent_app_number] => 09/535675 [patent_app_country] => US [patent_app_date] => 2000-03-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 110551 [patent_no_of_claims] => 39 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/667/06667299.pdf [firstpage_image] =>[orig_patent_app_number] => 09535675 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1009431 [patent_doc_number] => 06900193 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2005-05-31 [patent_title] => 'Structural modification of 19-norprogesterone I: 17-α-substituted-11-β-substituted-4-aryl and 21-substituted 19-norpregnadienedione as new antiprogestational agents' [patent_app_type] => utility [patent_app_number] => 09/526855 [patent_app_country] => US [patent_app_date] => 2000-03-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 14 [patent_no_of_words] => 72837 [patent_no_of_claims] => 56 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/900/06900193.pdf [firstpage_image] =>[orig_patent_app_number] => 09526855 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1056479 [patent_doc_number] => 06855703 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2005-02-15 [patent_title] => 'Pharmaceutical compositions of conjugated estrogens and methods of analyzing mixtures containing estrogenic compounds' [patent_app_type] => utility [patent_app_number] => 09/524132 [patent_app_country] => US [patent_app_date] => 2000-03-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 20550 [patent_no_of_claims] => 44 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 39 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/855/06855703.pdf [firstpage_image] =>[orig_patent_app_number] => 09524132 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1028012 [patent_doc_number] => 06881728 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2005-04-19 [patent_title] => '14-β, 17-α-hydroxymethylandrostane derivatives as androgens' [patent_app_type] => utility [patent_app_number] => 09/890845 [patent_app_country] => US [patent_app_date] => 2000-03-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 23075 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 8 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/881/06881728.pdf [firstpage_image] =>[orig_patent_app_number] => 09890845 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4311911 [patent_doc_number] => 06316432 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-11-13 [patent_title] => 'Antigestagenically active steroids with a flourinated 17 .alpha.-alkyl chain' [patent_app_type] => 1 [patent_app_number] => 9/516359 [patent_app_country] => US [patent_app_date] => 2000-03-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10792 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 382 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/316/06316432.pdf [firstpage_image] =>[orig_patent_app_number] => 516359 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4421649 [patent_doc_number] => 06225305 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-05-01 [patent_title] => 'Substituted urea and isothiorea derivatives as no synthase inhibitors' [patent_app_type] => 1 [patent_app_number] => 9/514525 [patent_app_country] => US [patent_app_date] => 2000-02-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11462 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 92 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/225/06225305.pdf [firstpage_image] =>[orig_patent_app_number] => 514525 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1470399 [patent_doc_number] => 06407142 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-06-18 [patent_title] => 'Use of stilbene derivatives substituted in position 3 as deodorant active agents in cosmetic compositions' [patent_app_type] => B1 [patent_app_number] => 09/504724 [patent_app_country] => US [patent_app_date] => 2000-02-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3828 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 40 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/407/06407142.pdf [firstpage_image] =>[orig_patent_app_number] => 09504724 [rel_patent_id] =>[rel_patent_doc_number] =>)